SB 844: Sickle Cell Disease Care Management and Treatment Continuing Education
GENERAL BILL by Jones
Sickle Cell Disease Care Management and Treatment Continuing Education; Revising requirements for a continuing education course on prescribing controlled substances which health care practitioners are required to complete; requiring the applicable licensing boards for specified health care professions to require a 2-hour continuing education course on sickle cell disease care management as part of the first licensure or certification renewal; specifying requirements for the course; authorizing the applicable boards to approve additional equivalent courses to satisfy the requirement, etc.
Last Action: 2/9/2026 Senate - On Committee agenda-- Appropriations Committee on Health and Human Services, 02/12/26, 2:30 pm, 412 Knott Building
Bill Text: Web Page | PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 12/10/2025 | Senate |
• Filed |
| 12/16/2025 | Senate |
• Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy |
| 1/13/2026 | Senate |
• Introduced |
| 1/28/2026 | Senate |
• On Committee agenda-- Health Policy, 02/02/26, 3:30 pm, 412 Knott Building |
| 2/2/2026 | Senate |
• Favorable by Health Policy; YEAS 11 NAYS 0 |
| 2/3/2026 | Senate |
• Now in Appropriations Committee on Health and Human Services |
| 2/9/2026 | Senate |
• On Committee agenda-- Appropriations Committee on Health and Human Services, 02/12/26, 2:30 pm, 412 Knott Building |